
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
L-type Ca++ CP γ8 CRISPR/Cas9 KO Plasmid (h) | sc-407391 | 20 µg | $397.00 |
CACNG8 encodes the L-type Ca++ channel auxiliary subunit γ8, a transmembrane regulator that modulates trafficking, gating, and membrane stability of voltage-gated calcium channel complexes in excitable cells. By tuning Ca2+ influx, γ8 influences calcium-dependent signaling networks that couple membrane depolarization to downstream pathways controlling neuronal excitability, synaptic transmission, and activity-dependent gene expression. Altered CACNG8 function has been implicated in neurophysiological phenotypes and may contribute to mechanisms relevant to seizure susceptibility and other disorders linked to dysregulated calcium signaling. As a component of ion channel macromolecular assemblies, CACNG8 provides a handle for studying channel complex composition and the cellular consequences of perturbing auxiliary subunits.
L-type Ca++ CP γ8 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the CACNG8 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the CACNG8 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the CACNG8 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish L-type Ca++ CP γ8 protein expression.
This CRISPR knockout system enables efficient generation of CACNG8-deficient cell models for investigation of L-type Ca++ CP γ8 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.